Had a flick through the September newsletter ... nothing that wasn't already known IMO
Azercel advancing, potention phase 2/3 trial package for FDA evaluation.
MAST trial advancing, ODD for Vaxinia.
OnCARlyitcs prelim data before the end of the year.
"We remain as focused as ever on advancing our highly prospective portfolio of cancer therapies and improving patient outcomes. We anticipate a busy end to the year and look forward to bringing you more via the ASX and our other communication channels"
Fingers crossed for PH's sake.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 5795292 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3258567 | 9 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |